Hoth Therapeutics is a biotechnology business based in the US. Hoth Therapeutics stocks (HOTH.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.59 – the same closing value as a week prior. Hoth Therapeutics employs 2 staff and has a market cap (total outstanding stock value) of $5.3 million.
How to buy Hoth Therapeutics stock
- Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – HOTH. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
National Bank Direct Brokerage
- Commission-free trading
- Several account types available
- Access to array of research tools
Interactive Brokers
- Access to international stock exchanges
- Low margin rates
- Powerful research tools
What's in this guide?
- Can I buy shares in Hoth Therapeutics?
- Has coronavirus impacted Hoth Therapeutics shares?
- Hoth Therapeutics shares summary
- Compare share dealing platforms
- Is Hoth Therapeutics stock a buy or sell?
- Hoth Therapeutics performance over time
- Hoth Therapeutics's financials
- How volatile are Hoth Therapeutics shares?
- Does Hoth Therapeutics pay a dividend?
- Have Hoth Therapeutics shares ever split?
- Other common questions
Hoth Therapeutics stock price (NASDAQ:HOTH)
Use our graph to track the performance of HOTH stocks over time.Hoth Therapeutics shares at a glance
Latest market close | $1.59 |
---|---|
52-week range | $1.52 - $12.75 |
50-day moving average | $1.86 |
200-day moving average | $5.04 |
Wall St. target price | $9.50 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-7.65 |
Buy Hoth Therapeutics stocks from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Is it a good time to buy Hoth Therapeutics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Hoth Therapeutics price performance over time
Historical closes compared with the close of $1.59 from 2023-05-26
1 week (2023-05-22) | 1.59 |
---|---|
1 month (2023-04-28) | -8.09% |
3 months (2023-03-01) | -43.42% |
6 months (2022-11-29) | -61.87% |
1 year (2022-05-25) | N/A |
---|---|
2 years (2021-05-28) | 9.66% |
3 years (2020-05-29) | 2.89 |
5 years (2018-05-25) | N/A |
Hoth Therapeutics financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -77.95% |
Return on equity TTM | -151.59% |
Profit margin | 0% |
Book value | $3.93 |
Market capitalisation | $5.3 million |
TTM: trailing 12 months
Hoth Therapeutics share dividends
We're not expecting Hoth Therapeutics to pay a dividend over the next 12 months.
Have Hoth Therapeutics's shares ever split?
Hoth Therapeutics's shares were split on a 1:25 basis on 26 October 2022. So if you had owned 25 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Hoth Therapeutics shares – just the quantity. However, indirectly, the new 2400% higher share price could have impacted the market appetite for Hoth Therapeutics shares which in turn could have impacted Hoth Therapeutics's share price.
Hoth Therapeutics share price volatility
Over the last 12 months, Hoth Therapeutics's shares have ranged in value from as little as $1.52 up to $12.745. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Hoth Therapeutics's is 0.1153. This would suggest that Hoth Therapeutics's shares are less volatile than average (for this exchange).
Hoth Therapeutics overview
Hoth Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on developing therapies for unmet medical needs. It is involved in the development of HT-001, a topical formulation, which is in Phase II clinical trial for the treatment of patients with rash and skin disorders associated with initial and repeat courses of tyrosine kinase epidermal growth factor receptor inhibitor therapy; HT-KIT to treat mast-cell derived cancers and anaphylaxis; HT-TBI to treat traumatic brain injury and ischemic stroke; HT-ALZ for the treatment and/or prevention of Alzheimer's or other neuroinflammatory diseases; HT-004 for treatment of asthma and allergies using inhalational administration; HT-003 for the treatment of acne and psoriasis, as well as inflammatory bowel diseases; and HT-002, a novel peptide for treating COVID-19. The company is also developing BioLexa Platform, a proprietary, patented, drug compound platform which is in Phase I clinical trial for the treatment of eczema; and HT-005 for treating patients with lupus, as well as a diagnostic device through a mobile device. The company has license agreements with the George Washington University; Isoprene Pharmaceuticals, Inc. ; Virginia Commonwealth University; the North Carolina State University; Chelexa BioSciences, Inc. and the University of Cincinnati; Zylö Therapeutics, Inc.
Stocks similar to Hoth Therapeutics
Hoth Therapeutics in the news
Lifshitz Law PLLC Announces Investigations of HOTH, ASRT, SPPI, and CEI
Frequently asked questions
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.
More on investing

How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…
Best stock app for beginners for 2023
The best stock trading app for beginners is easy to use and offers free trades.
Read more…
How to read stock charts
Learning how to read stock charts and recognize chart patterns can unlock your success as a trader.
Read more…More guides on Finder
-
Guide to finding the best prepaid card in Canada in May 2023
We show you the best prepaid credit cards in Canada, whether you’re looking for a prepaid card with no fees, cash back rewards, or travel perks, or more.
-
How to buy () in Canada
This guide provides step-by-step instructions on how to buy , lists some exchanges where you can get it and provides daily price data on ().
-
5 apps like Nyble in Canada
Compare apps like Nyble in Canada to access emergency funding.
-
RightRide review
Your guide to buying and financing a car in Canada with RightRide.
-
Compare bad credit car loans in BC
Your guide to bad credit car loans in BC and how to find the right financing for your needs.
-
Camera financing in Canada
Compare six ways to finance a camera in Canada, including options for good and bad credit.
-
How to buy () in Canada
This guide provides step-by-step instructions on how to buy , lists some exchanges where you can get it and provides daily price data on ().
-
Personal loans in Saskatchewan up to $50,000
Compare lenders to find the best personal loan in Saskatchewan for your needs.
-
Compare bad credit loans in Winnipeg
Compare interest rates and eligibility requirements of bad credit loans in Winnipeg.
-
Money Management for Teens: 7 Tips from Financial Experts
Teaching teenagers how to budget can be a tricky task. 7 experts give their best tips on how to budget for teenagers.